Topic
Genomically Informed Therapies and Biomarkers for Pediatric Solid Organs

Presented By
Neerav N. Shukla, assistant attending physician; director, Pediatric Tranlational Medicine program, Department of Pediatrics, Memorial Sloan Kettering Cancer Center

Learning Objectives
At the conclusion of the activity, participants should be able to:

• Explain the rationale behind development of genomically targeted therapeutics for pediatric solid tumors
• Enumerate the pros and cons of targeted DNA sequencing versus whole genome sequencing for clinical application in pediatric oncology
• Describe the multiple potential utilities of circulating tumor DNA analysis in pediatric solid tumors

Target Audience
Physicians, pediatricians, family and general practitioners, nurse practitioners, nursing personnel, fellows, residents and medical students

Continuing Medical Education Credits
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the PA Medical Society. St. Christopher’s Hospital for Children is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

St. Christopher’s Hospital for Children designates this live activity for a maximum of 1 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the educational activity.

Disclosure
Speakers and all others who have the ability to control the content of continuing medical education activities sponsored by St. Christopher’s Hospital for Children are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).

Additional Information
Continental breakfast is available at 7:30 a.m. outside DiGeorge Center. Parking passes for visiting physicians are available.